1.
Aniridia-associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets.
Szentmáry N, Suiwal S, Amini M, Fries F N, Náray A, Latta L et al.
Acta OphthalmolFeb 20261 citationsReview
Aniridia-associated keratopathy involves complex developmental, inflammatory, and limbal microenvironment changes. This understanding, including specific molecular targets, offers new therapeutic avenues to improve patient quality of life.